Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome
Launched by CAIRO UNIVERSITY · Aug 22, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well three different treatments—acupuncture, dry needle therapy, and Botox injections—can help manage myofascial pain dysfunction syndrome (MPDS). MPDS causes pain and muscle spasms, often in the jaw and face area, and the study will measure how effective these treatments are over time using simple pain scales and special equipment to monitor muscle activity.
To participate, you need to be between 15 and 60 years old and have signs of MPDS, such as pain in your jaw muscles. The study is open to both men and women and includes healthy volunteers. However, certain health conditions might prevent you from joining, like severe bleeding disorders, major mental health issues, or if you're pregnant. If you decide to participate, you’ll receive one of the treatments and then be followed up at 2 and 6 months to see how you’re doing. This trial aims to provide valuable information on managing this painful condition effectively.
Gender
ALL
Eligibility criteria
- • Accepts Healthy Volunteers
- Inclusion Criteria:
- • Healthy Volunteers
- • MPDS patient
- • Adult patients of both sexes, aged from 15 to 60 years
- • signs and symptoms of pain or muscles spams
- • Trigger points in masticatory muscles
- • Patients had not received any other form of surgical treatment related to TMJ disorders
- • Cooperative patient
- Exclusion Criteria:
- • Severe bleeding tendency, e.g. anticoagulant therapy, thrombocytopenia
- • Edentulous patients, and total dental prosthesis.
- • Psychologically disturbed and mental disturbance patients
- • major systemic disorders (- Valvular heart disease: avoid indwelling needles)
- • seizure patients
- • A confirmed or suspected diagnosis of an inflammatory disorder and autoimmune.
- • Patient on Medication (insulin- corticosteroids, nonsteroidal anti-inflammatory therapy or narcotics, muscle relaxants, herbal medicines.)
- • Analgesic or anti-depressants over the last 2 weeks.
- • Any anatomical abnormality in TMJ.
- • Pregnant women.
- • Allergies to metals.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported